Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 55

1.

VANGL1 Is Not Associated With the Susceptibility of Adolescent Idiopathic Scoliosis in the Chinese Population.

Xu L, Sheng F, Xia C, Feng Z, Qiu Y, Zhu Z.

Spine (Phila Pa 1976). 2018 May 15;43(10):E580-E584. doi: 10.1097/BRS.0000000000002497.

PMID:
29189642
2.

Mutation of the Planar Cell Polarity Gene VANGL1 in Adolescent Idiopathic Scoliosis.

Andersen MR, Farooq M, Koefoed K, Kjaer KW, Simony A, Christensen ST, Larsen LA.

Spine (Phila Pa 1976). 2017 Jun 15;42(12):E702-E707. doi: 10.1097/BRS.0000000000001927.

PMID:
27755493
3.

A novel DNA biosensor integrated with Polypyrrole/streptavidin and Au-PAMAM-CP bionanocomposite probes to detect the rs4839469 locus of the vangl1 gene for dysontogenesis prediction.

Li Q, Yu C, Gao R, Xia C, Yuan G, Li Y, Zhao Y, Chen Q, He J.

Biosens Bioelectron. 2016 Jun 15;80:674-681. doi: 10.1016/j.bios.2016.02.025. Epub 2016 Feb 10.

PMID:
26914375
4.

A novel electrochemical immunosensor based on the rGO-TEPA-PTC-NH₂ and AuPt modified C₆₀ bimetallic nanoclusters for the detection of Vangl1, a potential biomarker for dysontogenesis.

Chen Q, Yu C, Gao R, Gao L, Li Q, Yuan G, He J.

Biosens Bioelectron. 2016 May 15;79:364-70. doi: 10.1016/j.bios.2015.12.063. Epub 2015 Dec 21.

PMID:
26735870
5.

Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.

Oh HH, Park KJ, Kim N, Park SY, Park YL, Oak CY, Myung DS, Cho SB, Lee WS, Kim KK, Joo YE.

Oncol Rep. 2016 Jan;35(1):253-60. doi: 10.3892/or.2015.4337. Epub 2015 Oct 20.

PMID:
26496979
6.

Downregulation of VANGL1 inhibits cellular invasion rather than cell motility in hepatocellular carcinoma cells without stimulation.

Cetin GO, Toylu A, Atabey N, Sercan Z, Sakizli M.

Genet Test Mol Biomarkers. 2015 Jun;19(6):283-7. doi: 10.1089/gtmb.2015.0014. Epub 2015 Apr 15.

7.

KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers.

Lee KH, Ahn EJ, Oh SJ, Kim O, Joo YE, Bae JA, Yoon S, Ryu HH, Jung S, Kim KK, Lee JH, Moon KS.

Oncotarget. 2015 Feb 20;6(5):3240-53.

8.

Expanding the mutational spectrum associated to neural tube defects: literature revision and description of novel VANGL1 mutations.

Merello E, Mascelli S, Raso A, Piatelli G, Consales A, Cama A, Kibar Z, Capra V, Marco PD.

Birth Defects Res A Clin Mol Teratol. 2015 Jan;103(1):51-61. doi: 10.1002/bdra.23305. Epub 2014 Sep 10.

PMID:
25208524
9.

The intracellular carboxyl terminal domain of Vangl proteins contains plasma membrane targeting signals.

Iliescu A, Gros P.

Protein Sci. 2014 Apr;23(4):337-43. doi: 10.1002/pro.2432. Epub 2014 Mar 10.

10.

Association between VANGL1 gene polymorphisms and neural tube defects.

Cai C, Shi O, Wang B, Chang B, Yang R, Wang Y, Wang F, Shen C.

Neuropediatrics. 2014 Aug;45(4):234-9. doi: 10.1055/s-0033-1364103. Epub 2014 Jan 9.

PMID:
24407469
11.

Expression of KITENIN and its association with tumor progression in oral squamous cell carcinoma.

Yoon TM, Kim SA, Lee JK, Park YL, Kim GY, Joo YE, Lee JH, Kim KK, Lim SC.

Auris Nasus Larynx. 2013 Apr;40(2):222-6. doi: 10.1016/j.anl.2012.07.006. Epub 2012 Jul 25.

PMID:
22840317
12.

Expression of KITENIN in human colorectal cancer and its relation to tumor behavior and progression.

Lee S, Song YA, Park YL, Cho SB, Lee WS, Lee JH, Chung IJ, Kim KK, Rew JS, Joo YE.

Pathol Int. 2011 Apr;61(4):210-20. doi: 10.1111/j.1440-1827.2011.02646.x. Epub 2011 Mar 7.

PMID:
21418393
13.

Transmembrane topology of mammalian planar cell polarity protein Vangl1.

Iliescu A, Gravel M, Horth C, Apuzzo S, Gros P.

Biochemistry. 2011 Mar 29;50(12):2274-82. doi: 10.1021/bi101767a. Epub 2011 Feb 25.

PMID:
21291170
14.

Novel mutations in VANGL1 in neural tube defects.

Kibar Z, Bosoi CM, Kooistra M, Salem S, Finnell RH, De Marco P, Merello E, Bassuk AG, Capra V, Gros P.

Hum Mutat. 2009 Jul;30(7):E706-15. doi: 10.1002/humu.21026.

15.

KITENIN increases invasion and migration of mouse squamous cancer cells and promotes pulmonary metastasis in a mouse squamous tumor model.

Lee JK, Bae JA, Sun EG, Kim HD, Yoon TM, Kim K, Lee JH, Lim SC, Kim KK.

FEBS Lett. 2009 Feb 18;583(4):711-7. doi: 10.1016/j.febslet.2009.01.014. Epub 2009 Jan 21.

16.

Mutations in VANGL1 associated with neural-tube defects.

Kibar Z, Torban E, McDearmid JR, Reynolds A, Berghout J, Mathieu M, Kirillova I, De Marco P, Merello E, Hayes JM, Wallingford JB, Drapeau P, Capra V, Gros P.

N Engl J Med. 2007 Apr 5;356(14):1432-7.

17.

Analysis of the planar cell polarity gene Vangl2 and its co-expressed paralogue Vangl1 in neural tube defect patients.

Doudney K, Ybot-Gonzalez P, Paternotte C, Stevenson RE, Greene ND, Moore GE, Copp AJ, Stanier P.

Am J Med Genet A. 2005 Jul 1;136(1):90-2. No abstract available. Erratum in: Am J Med Genet A. 2005 Nov 1;138(4):415.

PMID:
15952208
18.

Isolation and characterization of a novel human gene, VANGL1, as a therapeutic target for hepatocellular carcinoma.

Yagyu R, Hamamoto R, Furukawa Y, Okabe H, Yamamura T, Nakamura Y.

Int J Oncol. 2002 Jun;20(6):1173-8.

PMID:
12011995
19.

Molecular cloning and characterization of Strabismus 2 (STB2).

Katoh M.

Int J Oncol. 2002 May;20(5):993-8.

PMID:
11956595
20.

Silencing of Kangai 1 C-terminal interacting tetraspanin suppresses progression of cholangiocarcinoma.

Bui KC, Barat S, Chen X, Bozko P, Scholta T, Nguyen MLT, Bhuria V, Xing J, Nguyen LT, Le HS, Velavan TP, Sipos B, Wilkens L, Malek NP, Plentz RR.

Exp Cell Res. 2018 Mar 1;364(1):59-67. doi: 10.1016/j.yexcr.2018.01.028. Epub 2018 Jan 31.

PMID:
29366806

Supplemental Content

Support Center